Remimazolam is an ultra short-acting benzodiazepine derivative that is structurally related to midazolam, with sedative-hypnotic activity. It is used in the induction and maintenance of sedation during short (<30 minute) procedures.
| Product Name |
Remimazolam Besylate |
| Description |
|
| CAS Number |
1001415-66-2 |
| Therapeutic Class |
Anesthetic Adjunct, Sedative, Benzodiazepines |
| Dosage Form |
Intravenous Injection |
| Availability |
Under Development |
| Regulatory Status |
|